JP2025505662A5 - - Google Patents

Info

Publication number
JP2025505662A5
JP2025505662A5 JP2024547024A JP2024547024A JP2025505662A5 JP 2025505662 A5 JP2025505662 A5 JP 2025505662A5 JP 2024547024 A JP2024547024 A JP 2024547024A JP 2024547024 A JP2024547024 A JP 2024547024A JP 2025505662 A5 JP2025505662 A5 JP 2025505662A5
Authority
JP
Japan
Prior art keywords
seq
raav
pharmaceutical composition
promoter
glut1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2024547024A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505662A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062231 external-priority patent/WO2023154763A2/en
Publication of JP2025505662A publication Critical patent/JP2025505662A/ja
Publication of JP2025505662A5 publication Critical patent/JP2025505662A5/ja
Withdrawn legal-status Critical Current

Links

JP2024547024A 2022-02-08 2023-02-08 Glut1発現用アデノ随伴ウイルスベクターおよびその使用 Withdrawn JP2025505662A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263307963P 2022-02-08 2022-02-08
US63/307,963 2022-02-08
PCT/US2023/062231 WO2023154763A2 (en) 2022-02-08 2023-02-08 Adeno-associated viral vector for glut1 expression and uses thereof

Publications (2)

Publication Number Publication Date
JP2025505662A JP2025505662A (ja) 2025-02-28
JP2025505662A5 true JP2025505662A5 (https=) 2026-02-02

Family

ID=87565090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547024A Withdrawn JP2025505662A (ja) 2022-02-08 2023-02-08 Glut1発現用アデノ随伴ウイルスベクターおよびその使用

Country Status (11)

Country Link
US (1) US20250135040A1 (https=)
EP (1) EP4475873A2 (https=)
JP (1) JP2025505662A (https=)
KR (1) KR20240142487A (https=)
CN (1) CN118843473A (https=)
AU (1) AU2023217712A1 (https=)
CA (1) CA3243383A1 (https=)
CL (1) CL2024002376A1 (https=)
IL (1) IL314602A (https=)
MX (1) MX2024009685A (https=)
WO (1) WO2023154763A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE055862T2 (hu) 2016-04-20 2021-12-28 Centro De Investig Energeticas Készítmények és eljárások PKLR fokozott génexpressziójára
SG11202002263TA (en) 2017-10-16 2020-04-29 Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas Lentiviral vectors for delivery of pklr to treat pyruvate kinase deficiency
WO2019200167A1 (en) 2018-04-11 2019-10-17 Rocket Pharmaceuticals, Ltd. Compositions and methods for stem cell transplant
MX2020011386A (es) 2018-04-27 2021-01-29 Spacecraft Seven Llc Terapia genica para la degeneracion del snc.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014207498A1 (de) * 2014-04-17 2015-10-22 Universitätsklinikum Hamburg-Eppendorf Viraler Vektor für den zielgerichteten Gentransfer in Gehirn und Rückenmark
EP3256170B1 (en) * 2015-02-13 2020-09-23 University of Massachusetts Compositions and methods for transient delivery of nucleases
KR20240119152A (ko) * 2015-03-10 2024-08-06 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 재조합 glut1 아데노-관련 바이러스 벡터 작제물 및 glut1 발현을 회복하기 위한 관련된 방법

Similar Documents

Publication Publication Date Title
JP2025505662A5 (https=)
JP2023538519A5 (https=)
Liu et al. Crossing the blood-brain barrier with AAV vectors
JP2023536902A5 (https=)
ES2714007T3 (es) Composiciones de vectores rAAV que tienen proteínas de la cápside modificadas en tirosina y métodos para su uso
EP3313991B1 (en) Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues
AU2019201861A1 (en) Widespread gene delivery of gene therapy vectors
JP2023536618A5 (https=)
JP2020510428A5 (https=)
GB2574243A (en) Adeno-associated viral vector-mediated gene therapy for treating fragile X-associated disorders
JP2024546103A5 (https=)
JP2025512574A5 (https=)
US12534741B2 (en) Compositions and methods for treatment of neurological disorders
JP2024545507A5 (https=)
JP2023537903A5 (https=)
JP2023503850A5 (https=)
JP2022539156A (ja) ヒアルロン酸を用いた眼組織へのaav媒介形質導入の増強
CA3207161A1 (en) Methods and compositions for treatment of friedreich's ataxia
JP2022545378A5 (https=)
JP2022525848A5 (https=)
RU2024125682A (ru) Вирусный вектор на основе аденоассоциированного вируса для экспрессии glut1 и варианты его применения
AU2020366242A1 (en) Materials and methods for the treatment of disorders associated mutations in the IRF2BPL gene
RU2025121437A (ru) Генная терапия для плакофилина-2 (pkp2) с применением вектора на основе aav
EP4326882B1 (en) Methods and means for the prevention and/or treatment of hemophilic arthropathy in hemophilia
US20250144243A1 (en) Aav capsids for improved heart transduction and detargeting of liver